Significant lower expression of miR-29a/29b and higher expression level of two potential target genes Bcl-2 and Mcl-1 were found in PBMCs from AML and CML patients compared with HI group. This evidence concerns the gene BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive.